148 related articles for article (PubMed ID: 31763369)
1. Cytochrome P450 monooxygenase/soluble epoxide hydrolase-mediated eicosanoid pathway in colorectal cancer and obesity-associated colorectal cancer.
Zhang J; Sanidad KZ; Zhang G
Oncoscience; 2019 Sep; 6(9-10):371-375. PubMed ID: 31763369
[TBL] [Abstract][Full Text] [Related]
2. Cytochrome P450 Eicosanoid Signaling Pathway in Colorectal Tumorigenesis.
Wang W; Sanidad KZ; Zhang G
Adv Exp Med Biol; 2019; 1161():115-123. PubMed ID: 31562626
[TBL] [Abstract][Full Text] [Related]
3. Eicosanoid signaling in carcinogenesis of colorectal cancer.
Wang Y; Wang W; Sanidad KZ; Shih PA; Zhao X; Zhang G
Cancer Metastasis Rev; 2018 Sep; 37(2-3):257-267. PubMed ID: 29858741
[TBL] [Abstract][Full Text] [Related]
4. Integrating multi-omics biomarkers and postprandial metabolism to develop personalized treatment for anorexia nervosa.
Shih PB
Prostaglandins Other Lipid Mediat; 2017 Sep; 132():69-76. PubMed ID: 28232135
[TBL] [Abstract][Full Text] [Related]
5. Cytochrome P450-dependent eicosanoid production and crosstalk.
Fleming I
Curr Opin Lipidol; 2011 Oct; 22(5):403-9. PubMed ID: 21825980
[TBL] [Abstract][Full Text] [Related]
6. EETs/sEH in diabetes and obesity-induced cardiovascular diseases.
Huang H; Weng J; Wang MH
Prostaglandins Other Lipid Mediat; 2016 Sep; 125():80-9. PubMed ID: 27184755
[TBL] [Abstract][Full Text] [Related]
7. Renal Ischemia/Reperfusion Injury in Soluble Epoxide Hydrolase-Deficient Mice.
Zhu Y; Blum M; Hoff U; Wesser T; Fechner M; Westphal C; Gürgen D; Catar RA; Philippe A; Wu K; Bubalo G; Rothe M; Weldon SM; Dragun D; Schunck WH
PLoS One; 2016; 11(1):e0145645. PubMed ID: 26727266
[TBL] [Abstract][Full Text] [Related]
8. Lipidomic profiling reveals soluble epoxide hydrolase as a therapeutic target of obesity-induced colonic inflammation.
Wang W; Yang J; Zhang J; Wang Y; Hwang SH; Qi W; Wan D; Kim D; Sun J; Sanidad KZ; Yang H; Park Y; Liu JY; Zhao X; Zheng X; Liu Z; Hammock BD; Zhang G
Proc Natl Acad Sci U S A; 2018 May; 115(20):5283-5288. PubMed ID: 29717038
[TBL] [Abstract][Full Text] [Related]
9. Time-dependent expression pattern of cytochrome P450 epoxygenases and soluble epoxide hydrolase in normal human placenta.
Cizkova K; Tauber Z
Acta Histochem; 2018 Aug; 120(6):513-519. PubMed ID: 29908721
[TBL] [Abstract][Full Text] [Related]
10. Epoxy-Oxylipins and Soluble Epoxide Hydrolase Metabolic Pathway as Targets for NSAID-Induced Gastroenteropathy and Inflammation-Associated Carcinogenesis.
Jones RD; Liao J; Tong X; Xu D; Sun L; Li H; Yang GY
Front Pharmacol; 2019; 10():731. PubMed ID: 31293429
[TBL] [Abstract][Full Text] [Related]
11. Cyclooxygenase- and cytochrome P450-derived eicosanoids in stroke.
Huang H; Al-Shabrawey M; Wang MH
Prostaglandins Other Lipid Mediat; 2016 Jan; 122():45-53. PubMed ID: 26747234
[TBL] [Abstract][Full Text] [Related]
12. Role of Cytochrome p450 and Soluble Epoxide Hydrolase Enzymes and Their Associated Metabolites in the Pathogenesis of Diabetic Cardiomyopathy.
Maayah ZH; McGinn E; Al Batran R; Gopal K; Ussher JR; El-Kadi AOS
J Cardiovasc Pharmacol; 2019 Sep; 74(3):235-245. PubMed ID: 31306370
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of soluble epoxide hydrolase modulates inflammation and autophagy in obese adipose tissue and liver: role for omega-3 epoxides.
López-Vicario C; Alcaraz-Quiles J; García-Alonso V; Rius B; Hwang SH; Titos E; Lopategi A; Hammock BD; Arroyo V; Clària J
Proc Natl Acad Sci U S A; 2015 Jan; 112(2):536-41. PubMed ID: 25550510
[TBL] [Abstract][Full Text] [Related]
14. Acute mercury toxicity modulates cytochrome P450, soluble epoxide hydrolase and their associated arachidonic acid metabolites in C57Bl/6 mouse heart.
Amara IE; Elshenawy OH; Abdelrady M; El-Kadi AO
Toxicol Lett; 2014 Apr; 226(1):53-62. PubMed ID: 24472606
[TBL] [Abstract][Full Text] [Related]
15. Research progress on the protective mechanism of a novel soluble epoxide hydrolase inhibitor TPPU on ischemic stroke.
Huang P
Front Neurol; 2023; 14():1083972. PubMed ID: 36846137
[TBL] [Abstract][Full Text] [Related]
16. Elevated 14,15- epoxyeicosatrienoic acid by increasing of cytochrome P450 2C8, 2C9 and 2J2 and decreasing of soluble epoxide hydrolase associated with aggressiveness of human breast cancer.
Wei X; Zhang D; Dou X; Niu N; Huang W; Bai J; Zhang G
BMC Cancer; 2014 Nov; 14():841. PubMed ID: 25406731
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of soluble epoxide hydrolase does not protect against endotoxin-mediated hepatic inflammation.
Fife KL; Liu Y; Schmelzer KR; Tsai HJ; Kim IH; Morisseau C; Hammock BD; Kroetz DL
J Pharmacol Exp Ther; 2008 Dec; 327(3):707-15. PubMed ID: 18815352
[TBL] [Abstract][Full Text] [Related]
18. Soluble epoxide hydrolase: a novel target for the treatment of hypertension.
Fang X
Recent Pat Cardiovasc Drug Discov; 2006 Jan; 1(1):67-72. PubMed ID: 18221075
[TBL] [Abstract][Full Text] [Related]
19. Angiogenesis and vascular stability in eicosanoids and cancer.
Hu J; Frömel T; Fleming I
Cancer Metastasis Rev; 2018 Sep; 37(2-3):425-438. PubMed ID: 29808461
[TBL] [Abstract][Full Text] [Related]
20. The Role of Soluble Epoxide Hydrolase Enzyme on Daunorubicin-Mediated Cardiotoxicity.
Maayah ZH; Abdelhamid G; Elshenawy OH; El-Sherbeni AA; Althurwi HN; McGinn E; Dawood D; Alammari AH; El-Kadi AOS
Cardiovasc Toxicol; 2018 Jun; 18(3):268-283. PubMed ID: 29196978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
